Lille

• Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting
  2024-513427-17-00 6 2021-05-20 Well controlled severe allergic asthma
• Isatuximab in combination with novel agents in RRMM – Master protocol and control arm Recruiting
  2024-514988-25-00 9 2021-03-31 Cancer
• Isatuximab in combination with SAR445761 (belumosudil) and dexamethasone in relapsed or refractory multiple myeloma Recruiting
  2024-514992-16-00 9 2021-03-31 Cancer
• Isatuximab in combination with evorpacept and dexamethasone in RRMM Recruiting
  2024-514993-38-00 9 2021-03-31 Cancer
• AGADIR : Atezolizumab combined with EIK10001 (BDB001) and Immunogenic Radiotherapy in Patients with Advanced Solid Tumors Recruiting
  2023-509492-16-00 4 2021-03-30 Adult participants with metastatic (advanced) solid tumors.
• RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR … Recruiting
  2022-502642-27-00 9 2020-11-26 RElapse in previously irradiated Prostate bed
• GROINSS-V III Recruiting
  2023-508722-99-00 4 2020-11-19 Vulvar cancer
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• SUBCUTANEOUS INJECTIONS OF AUTOLOGOUS CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WIT … Recruiting
  2023-508432-53-00 4 2020-09-22 Systemic sclerosis
• Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal … Recruiting
  2024-514542-37-00 9 2020-08-13 Select advanced solid tumors and Non-Small Cell Lung Cancer with MET a
• Pan tumor Roll Over Study Recruiting
  2023-506914-32-00 4 2020-05-05 Pan tumor
• A multicentre trial evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advance … Recruiting
  2024-510712-75-00 9 2020-02-12 advanced / metastatic
• Study describing the efficacy and safety of regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas Recruiting
  2024-514637-37-00 5 2020-02-11 Patients with bone sarcomas other than chordoma, who have no residual
• SIOP RANDOMET 2017 Recruiting
  2023-508926-91-00 5 2019-12-05 Stage IV childhood renal tumour with pulmonary +/- non-pulmonary metas
• LOADEX: PILOT AND PHASE 2 STUDY OF THE EFFICACY OF A TREATMENT PROTOCOL WITH DEXAMETHASONE IMPLANT LOADING DOSE IN PATIENTS WITH DIABETIC MA … Recruiting
  2024-514362-39-00 4 2019-12-05 Diabetic macular oedema
• MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remis … Recruiting
  2024-514156-33-00 5 2019-08-20 Patients in remission for granulomatosis with polyangiitis (GPA, Wegen
• A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer (PEACE 4) Recruiting
  2023-508072-11-00 5 2019-06-26 Castration-resistant prostate cancer
• An early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) Recruiting
  2024-515690-10-00 9 2019-05-10 Follicular B-cell non-Hodgkin's lymphoma
• A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting
  2023-508302-24-00 4 2019-05-07 Locally Advanced/Metastatic Urothelial Cancer
• PD-(L)1 iNhibitors with concurrent IRadiation at VAried tumour sites in advanced Non-small cell lung cAncer Recruiting
  2024-512173-27-00 5 2019-03-21 Advanced (stage IIIB/IIIC/IV) NSCLC patients eligible for treatment wi
• Atezolizumab After Chemo-radiotherapy for muscle-invasive bladder cancer Patients Not Eligible for Radical Cystectomy Recruiting
  2024-512002-26-00 4 2019-02-19 Muscle-invasive bladder cancer
• Trial that evaluates the interest of interruption versus maintaining the treatment of aromatase inhibitors in patients with metastatic low g … Recruiting
  2024-512629-97-00 4 2019-01-23 Patients with locally advanced or metastatic low grade endometrial str
• Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting
  2023-504201-36-00 10 2018-12-21 Defined by parent protocol. The study will enroll all adult and paedia
• Randomised trial evaluating mifamurtide in combination with standard chemotherapy in patients with high-grade osteosarcoma at high risk of r … Recruiting
  2024-514780-26-00 4 2018-10-23 Patients ≤50 years old with high-risk osteosarcoma (defined as metasta

Showing 337–360 of 686 trials